glutathione disulfide has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amouzad Mahdirejei, H; Azarbayjani, MA; Masrour, FF; Peeri, M | 1 |
| Bartolini, D; Bastianelli, S; Busti, C; Castronari, R; Cruciani, G; Di Cristina, M; Focaia, R; Francisci, D; Galli, F; Gidari, A; Gioiello, A; Giustarini, D; Mencacci, A; Pierucci, S; Rende, M; Rossi, R; Sabbatini, S; Stabile, AM; Vacca, C | 1 |
2 other study(ies) available for glutathione disulfide and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Diazepam and exercise training combination synergistically reduces lipopolysaccharide-induced anxiety-like behavior and oxidative stress in the prefrontal cortex of mice.
Topics: Animals; Anxiety; COVID-19; Diazepam; Glutathione; Glutathione Disulfide; Hippocampus; Humans; Lipopolysaccharides; Mice; Oxidative Stress; Pandemics; Prefrontal Cortex | 2023 |
SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione.
Topics: COVID-19; Glutathione; Glutathione Disulfide; Humans; Oxidation-Reduction; RNA, Viral; SARS-CoV-2 | 2021 |